Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

290 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics.
Deeb KK, Trump DL, Johnson CS. Deeb KK, et al. Among authors: trump dl. Nat Rev Cancer. 2007 Sep;7(9):684-700. doi: 10.1038/nrc2196. Nat Rev Cancer. 2007. PMID: 17721433 Review.
A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis.
Trump DL, Smith DC, Stiff D, Adedoyin A, Day R, Bahnson RR, Hofacker J, Branch RA. Trump DL, et al. Cancer Chemother Pharmacol. 1997;39(4):349-56. doi: 10.1007/s002800050582. Cancer Chemother Pharmacol. 1997. PMID: 9025776 Clinical Trial.
Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
Konety BR, Lavelle JP, Pirtskalaishvili G, Dhir R, Meyers SA, Nguyen TS, Hershberger P, Shurin MR, Johnson CS, Trump DL, Zeidel ML, Getzenberg RH. Konety BR, et al. Among authors: trump dl. J Urol. 2001 Jan;165(1):253-8. doi: 10.1097/00005392-200101000-00074. J Urol. 2001. PMID: 11125420
A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.
Ramnath N, Daignault-Newton S, Dy GK, Muindi JR, Adjei A, Elingrod VL, Kalemkerian GP, Cease KB, Stella PJ, Brenner DE, Troeschel S, Johnson CS, Trump DL. Ramnath N, et al. Among authors: trump dl. Cancer Chemother Pharmacol. 2013 May;71(5):1173-82. doi: 10.1007/s00280-013-2109-x. Epub 2013 Feb 23. Cancer Chemother Pharmacol. 2013. PMID: 23435876 Free PMC article. Clinical Trial.
Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans.
Willson JK, Fischer PH, Remick SC, Tutsch KD, Grem JL, Nieting L, Alberti D, Bruggink J, Trump DL. Willson JK, et al. Among authors: trump dl. Cancer Res. 1989 Apr 1;49(7):1866-70. Cancer Res. 1989. PMID: 2924325
Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors.
Fakih MG, Creaven PJ, Ramnath N, Trump D, Javle M, Strychor S, Repinski TV, Zamboni BA, Schwarz JK, French RA, Zamboni WC. Fakih MG, et al. Among authors: trump d. Clin Cancer Res. 2005 Aug 15;11(16):5942-9. doi: 10.1158/1078-0432.CCR-05-0116. Clin Cancer Res. 2005. PMID: 16115937 Clinical Trial.
Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S, Catalano PJ, Einhorn LH, Nichols CR, David Crawford E, Vogelzang N, Trump D, Loehrer PJ Sr. Hinton S, et al. Among authors: trump d. Cancer. 2003 Apr 15;97(8):1869-75. doi: 10.1002/cncr.11271. Cancer. 2003. PMID: 12673712 Clinical Trial.
Chemotherapy of prostate cancer: present and future.
Trump D, Lau YK. Trump D, et al. Curr Urol Rep. 2003 Jun;4(3):229-32. doi: 10.1007/s11934-003-0074-3. Curr Urol Rep. 2003. PMID: 12756087 Review.
Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer.
Wilding G, Soulie P, Trump D, Das-Gupta A, Small E. Wilding G, et al. Among authors: trump d. Cancer. 2006 May 1;106(9):1917-24. doi: 10.1002/cncr.21831. Cancer. 2006. PMID: 16568471 Clinical Trial.
Vitamin D deficiency and insufficiency among patients with prostate cancer.
Trump DL, Chadha MK, Sunga AY, Fakih MG, Ashraf U, Silliman CG, Hollis BW, Nesline MK, Tian L, Tan W, Johnson CS. Trump DL, et al. BJU Int. 2009 Oct;104(7):909-14. doi: 10.1111/j.1464-410X.2009.08531.x. Epub 2009 Apr 4. BJU Int. 2009. PMID: 19426195 Free PMC article.
290 results
Jump to page